CIRCULATION-OVERLAPPING SOLID-PHASE PREPARATION WITH COVERING BEING OUT OF IMMOBILIZED BINDING PREPARATION Russian patent published in 2007 - IPC A61K9/00 A61K9/16 A61K38/36 A61K38/39 A61K47/48 A61P35/00 A61L31/16 

Abstract RU 2295329 C2

FIELD: medicine.

SUBSTANCE: the present innovation deals with methods and compositions for targeted supply of circulation -overlapping solid-phase thrombocytes-binding preparations for treating vascularized tumor or hyperplastic tissue. The solid-phase preparation covered except polystyrene with thrombocytes-binding preparation, such as Willebrand's factor, should be purposefully directed towards vascular net-target in vivo, where it binds and activates thrombocytes which, in their turn, bind and activate other thrombocytes. Variant of composition for inducing thrombogenesis in vivo and containing a solid-phase thrombocytes-binding preparation, except polystyrene, could be consisted of the first binding component and the second binding component, where the first binding component has got binding area for binding a solid-phase preparation with a ligand-receptor complex, and not with a ligand or receptor separately, as for the second binding component it has got binding area for thrombocytes. The innovation provides rapid formation of a dense thrombus that leads to overlapping the circulation in the desired area due to thrombocytic fixation towards the surface of a solid-phase preparation along with increasing its sizes and developing a multi-layer structure of activated thrombocytes as a dense matrix.

EFFECT: higher efficiency.

29 cl, 12 ex, 2 tbl

Similar patents RU2295329C2

Title Year Author Number
METHOD FOR OVERLAPPING CIRCULATION AND COMPOSITIONS FOR THEIR REALIZATION 1999
  • Stevart Mikaehl' Vill'Jam
  • Person Roland Khenrik
  • N'Judzhejm Antoin
RU2227752C2
ISOLATED GLYCOPROTEIN IB ALPHA POLYPEPTIDE OF HUMAN THROMBOCYTES, FUSED PROTEIN, DNA MOLECULE (VERSIONS), EXPRESSION VECTOR (VERSIONS), CELL (VERSIONS), POLYPEPTIDE EXPRESSION METHOD, FUSED PROTEIN EXPRESSION METHOD, PHARMACEUTICAL COMPOSITION (VERSIONS), METHOD OF INHIBITING BODING OF BLOOD CELLS TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM, METHOD OF INHIBITING BONDING OF PROTEIN TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM AND DISORDER TREATMENT METHOD 2004
  • Sho Grej
  • Sako Dajann S.
  • Kumar Ravindra
  • Sjuj Tszin'
RU2403262C2
ANTI-THROMBOTIC AGENT AND HUMANIZED MONOCLONAL ANTIBODY RAISED AGAINST VON WILLEBRAND FACTOR 1999
  • Ko Man Sung
  • Vaskes Maksimil'Jano
RU2223785C2
BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY 2005
  • Nilsen Ulrik B.
  • Shoehberl' Birgit M.
RU2433831C2
COMPOSITIONS AND METHODS FOR INHIBITION OF STEM CELLS AND PRECURSOR CELLS BINDING WITH LYMPHOID TISSUE AND FOR REGENERATION OF GERMINAL CENTERS IN LYMPH TISSUES 2011
  • Dejsher Tereza
RU2645069C2
THERAPEUTIC POLYPEPTIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND APPLICATION THEREOF FOR MODULATION OF PLATELET-MEDIATED AGGREGATION 2004
  • Silans Karen
RU2524129C2
MODIFIERS OF GLYCOPROTEIN VI REPRESENTING NUCLEIC ACID 2010
  • Lehjzer Dzhuliana M.
  • Raskoni Kristofer P.
  • Bruks Duglas
  • Zelenkofske Stiven L.
RU2571660C2
COMBINED THERAPY BY USING ANTIANGIOGENIC AGENTS AND TNF-ALPHA 2002
  • Grell' Mattias
  • Gudman Sajmon
  • Rjugg Kurtsio
RU2316337C2
METHOD FOR DETECTING ANTIPLATELET DRUG RESISTANCE IN PATIENTS WITH PROGRESSING CEREBRAL ATHEROSCLEROSIS 2012
  • Tanashjan Marineh Movsesovna
  • Khamidova Zaira Magomedovna
  • Ionova Viktorija Grigor'Evna
  • Kostyreva Marina Vladimirovna
  • Shabalina Alla Anatol'Evna
RU2478965C1
PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 2008
  • Paskualini Renata
  • Arap Vadikh
  • Zhiurdanu Rikardu
  • Kardo-Vila Marina
  • Valente Ana Paula
  • Seneviva Laserda De Al'Mejda Fabiu
RU2488592C2

RU 2 295 329 C2

Authors

Stevart Michel V.

Noudzhajm Ehntoni A.

Pehson Roland Khenrik

Dates

2007-03-20Published

2002-09-11Filed